Director/PDMR Shareholding

RNS Number : 6924Q

Tristel PLC

24 October 2011

 



24 October 2011

TRISTEL plc

Director Shareholding

Tristel plc ("Tristel" or the "Company"), the manufacturer of infection control, contamination control and hygiene consumable products, announces that Ms Elizabeth Dixon, Finance Director, has today acquired 2,000 ordinary shares of 1p each in the Company at 39.95p each. 

Following this transaction Liz Dixon will be interested in 10,000 ordinary shares, representing 0.025% of the issued share capital of the Company.

For further information:

Tristel plc		Tel: [phone]
Paul Swinney, Chief Executive Liz Dixon, Finance Director
Walbrook PR Ltd		Tel: [phone]
Fiona Henson		Mob: [phone] or [e-mail]
Paul McManus		Mob: [phone] or [e-mail]
FinnCap
Geoff  Nash / Charlotte Stranner (Corporate Finance)		Tel: [phone]
Simon Starr (Corporate Broking)

About Tristel plc

Tristel plc is an infection prevention and contamination control business headquartered in Newmarket, United Kingdom.  Its products are used to prevent hospital acquired infections, for hygiene in animal healthcare and by pharmaceutical and personal care manufacturers for contamination control.  Its leading brands are Tristel (infection prevention) and Crystel (contamination control).  The Group's products are considered to be amongst the highest performing biocides available to healthcare and industry.  Tristel's lead technology is a proprietary chlorine dioxide formulation used to disinfect instruments and surfaces and to control legionella and biofilm build up in water.

Tristel was admitted to the London Stock Exchange AIM market in June 2005.  Its stock exchange symbol is TSTL.

 

END

 

 

RDSKMMZGRDGGMZG